medigraphic.com
ENGLISH

Annals of Hepatology

Órgano Oficial de la Asociación Mexicana de Hepatología
  • Mostrar índice
  • Números disponibles
  • Información
    • Información general        
    • Directorio
  • Publicar
    • Instrucciones para autores        
  • medigraphic.com
    • Inicio
    • Índice de revistas            
    • Registro / Acceso
  • Mi perfil

2006, Número S1

<< Anterior Siguiente >>

Ann Hepatol 2006; 5 (S1)


Module Vl
Treatment of Acute Hepatitis

Olivera MMA
Texto completo Cómo citar este artículo

Idioma: Ingles.
Referencias bibliográficas: 13
Paginas: 29-31
Archivo PDF: 43.32 Kb.


PALABRAS CLAVE

Sin palabras Clave

FRAGMENTO

Sin resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Rocca P, Bailly F, Chevalier M, Chevalier P, Zoulim F, Trépo C. Early treatment of acute hepatitis C with interferon alpha 2b or interferon alpha 2 b plus ribavirin: study of sixteen patients. Gastroenterol Clin Biol 2003; 27: 294-9.

  2. Pellicano R, Mladenova I, Dimitrova SM, Bruno CM, Sciacca C, Rizzetto M. The epidemiology of hepatitis C virus infection. An update for clinicians. Minerva Gastroenterol Dietol 2004; 50: 1-7.

  3. US Public Health Service. Updated U.S. public health service guidelines for the management of occupational exposures to HBV, HCV and HIV and recommendations for exposure prophylaxis. MMWR Recomm Rep 2001; 50(RR-11): 1-52.

  4. Moloughney BW. Transmission and postexposure management of bloodborne virus infections in the health care settings. Where are we now? CMAJ 2001; 165: 445-51.

  5. Watson KJR. Surgeon, test (and heal) thyself: sharps injuries and hepatitis C risk. MJA 2004; 181: 366-7.

  6. Thompson BJ, Finch RG. Hepatitis C virus infection. Clin Microbiol Infect 2005; 11: 86-94.

  7. Sarrazin U, Brodt R, Sarrzin C, Zeuzem S. Postexposure prevention after occupational exposure to HBV, HCV and HIV. Unfallchirurg 2004; 107: 129-42.

  8. O’Sullivan BG, Levy MH, Dolan KA, Post JJ, Barton, Dwyer DE, Kaldor JM, Grulich AE. Hepatitis C transmission and HIV postexposure prophylaxis after needle-and syringe-sharing in Australian prisons. MJA 2003; 178: 546-9.

  9. Desenclos JC, Bourdiol-Razes M, Rolin B, Garandeau P, Ducos J, Brechot T, Thiers V. Hepatitis C in a ward for cystic fibrosis and diabetic patients: possible transmission by spring-loaded fingerstick devices for self monitoring of capillary blood glucose. Infect Control Hosp Epidemiol 2002; 23: 298-9.

  10. Piazza MK, Sagliocca L, Tosone G, Guadagnino V, Stazi MA, Orlando R, Borgia G, Rosa D, Abrignani S, Palumbo F, Manzin A, Clementi M. Sexual transmission of hepatitis C virus and prevention with intramuscular immunoglobulin. AIDS Patient Care STDS 1998; 12: 611-8.

  11. Nomura H, Sou S, Tanimoto H, Nagahama T, Kimura Y, Hayashi J, Ishibashi H, Kashiwagi S. Short-term interferon alfa therapy for acute hepatitis C: a randomized controlled trial. Hepatology 2004; 39: 1213-9.

  12. Jaeckel E, Cornberg M, Wedemeyer H, et al. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 2001; 345: 1452-7.

  13. Rodríguez-Gómez SJ, De la Serna-Higuera C, Pérez-Villoria A, Martínez-Moreno J, Betancourt-González A, Martín-Arribas MI. Peginterferon and ribavirin in a patient with acute hepatitis C. Am J Gastroenterol 2003; 98: 2102-3.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ann Hepatol. 2006;5

ARTíCULOS SIMILARES

CARGANDO ...